Loading the records…
Loading the records…
KBR, Inc. ($KBR) received a $227 million delivery order from NASA for the Human Health and Performance Contract 2 (HHPC2), representing ~2.9% of its FY2025 revenue. This award bolsters KBR's position in NASA's human spaceflight support ecosystem and provides a clear revenue tailwind for the company's Government Solutions segment.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
The $227 million award to KBR ($KBR) under NASA's HHPC2 program signals continued federal investment in human spaceflight health services, a niche but essential segment of the space economy. For KBR, this contract adds directly to its funded backlog and supports its Government Solutions segment, which has been a stable growth driver. The award also validates KBR's competitive positioning for future NASA task orders, including those related to Artemis lunar missions. While the contract is not transformative for a company of KBR's size, it provides a measurable revenue and earnings contribution that can support stock performance relative to peers in the government services space, such as $BAH or $CACI. Investors should view this as a positive but incremental catalyst within KBR's broader portfolio.
The contract award to KBR WYLE SERVICES, LLC is a $227 million delivery order under NASA's Human Health and Performance Contract 2 (HHPC2). This program provides medical, health, and performance support for astronauts and mission crews, covering areas such as clinical care, biomedical research, and crew health monitoring. The period of performance runs from September 2025 through September 2026, indicating a focused one-year task order within a larger indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle.
KBR, Inc. ($KBR) is the publicly traded parent company, and this award directly adds to its funded backlog. With FY2025 revenue of $7.8 billion and net income of $415 million, the $227 million contract represents approximately 2.9% of annual revenue—a meaningful but not transformative contribution. However, given KBR's net margin of 5.33%, the contract could contribute roughly $12 million in net income if margins are consistent, providing a clear earnings tailwind. The company's Government Solutions segment, which includes NASA support, is a core growth driver.
No related legislation was identified in the provided bill signals that directly authorizes or appropriates funds for this specific NASA contract. The contract appears to be funded through existing NASA appropriations for human spaceflight operations, likely under the agency's Exploration Systems Development or Space Operations mission directorates. The absence of a direct legislative link does not diminish the contract's value; it reflects routine task order issuance under a previously awarded IDIQ.
Supply chain beneficiaries include smaller subcontractors specializing in aerospace medicine, biomedical monitoring equipment, and crew health data analytics. Companies like $BIO (BioLife Solutions) or $TMO (Thermo Fisher) could supply medical equipment, while $MAXR (Maxar) might provide satellite communications support for crew health data transmission. However, these are indirect and speculative; the primary beneficiary is KBR itself.
Historically, NASA human health and performance contracts have been stable, recurring revenue sources for prime contractors like KBR and its predecessor Wyle Laboratories. The transition to HHPC2 signals continued investment in astronaut health for Artemis missions and International Space Station operations. KBR's stock performance typically correlates with backlog growth and government services revenue visibility; this award reinforces a positive trajectory for the company's space-related services.
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Direct contract award via delivery order under NASA's Human Health and Performance Contract 2 (HHPC2) program
Who must act
National Aeronautics and Space Administration (NASA) to KBR WYLE SERVICES, LLC (a wholly owned subsidiary of KBR, Inc.)
What happens
$227 million added to KBR's funded backlog, representing approximately 2.9% of the company's FY2025 annual revenue of $7.8 billion
Stock impact
KBR's Government Solutions segment, which includes NASA human spaceflight support services, receives a substantial task order that reinforces its role as a key provider of medical and health performance services for astronauts. This contract contributes to the segment's revenue and profitability, with KBR's overall net margin at 5.33% in FY2025. The award also strengthens KBR's competitive position for future NASA human spaceflight contracts.
Matched on shared policy language across AI analyses, with ticker & timing weight
KBR WYLE SERVICES, LLC: $227M National Aeronautics and Space Administration Contract
KBR WYLE SERVICES, LLC: $219M National Aeronautics and Space Administration Contract
KBR WYLE SERVICES, LLC: $198M National Aeronautics and Space Administration Contract
KBR WYLE SERVICES, LLC: $219M National Aeronautics and Space Administration Contract
Executive orders & memoranda affecting the same sectors or companies
The President invokes Section 232 of the Trade Expansion Act to declare that imports of robotics, industrial machinery, and their components threaten national security, and directs the Secretary of Commerce and USTR to negotiate agreements with trading partners to adjust these imports, potentially leading to tariffs or quotas within 180 days.
This proclamation initiates negotiations to adjust imports of wind turbines and their components under Section 232, citing national security concerns including cybersecurity vulnerabilities, radar interference, and grid reliability. It does not immediately impose tariffs but sets the stage for potential trade restrictions, and notes that certain wind turbine components made of aluminum, steel, or copper are already subject to existing tariffs.
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
Recipient
KBR WYLE SERVICES, LLC
Award Amount
$226,584,486
Awarding Agency
National Aeronautics and Space Administration
Sub-Agency
National Aeronautics and Space Administration
Contract Type
DELIVERY ORDER
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →